UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 441

Sortiert nach

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy

Frontiers in immunology, 2021-04, Vol.12, p.654877

2021

Volltextzugriff (PDF)

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Cancer immunology research, 2018-04, Vol.6 (4), p.481-493

2018

Volltextzugriff (PDF)

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Frontiers in oncology, 2020-06, Vol.10

2020

Volltextzugriff (PDF)

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

Journal for immunotherapy of cancer, 2018-04, Vol.6 (1), p.25-25, Article 25

2018

Volltextzugriff (PDF)

Bevacizumab in breast cancer: a targeted therapy still in search of a target population

Seminars in oncology, 2017-08, Vol.44 (4), p.286-287

2017

Volltextzugriff (PDF)

Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men

Journal of acquired immune deficiency syndromes (1999), 2012-03, Vol.59 (3), p.259

2012

Volltextzugriff (PDF)

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer research (Chicago, Ill.), 2020-03, Vol.80 (5), p.1078-1087

2020

Volltextzugriff (PDF)

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Clinical cancer research, 2019-04, Vol.25 (8), p.2494-2502

2019

Volltextzugriff (PDF)

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

Clinical breast cancer, 2022-08, Vol.22 (6), p.538-546

2022

Volltextzugriff (PDF)

Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin

Cancer investigation, 2021-08, Vol.39 (6-7), p.466-472

2021

Volltextzugriff (PDF)

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

Melanoma research, 2020-08, Vol.30 (4), p.410

2020

Volltextzugriff (PDF)

The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-10, Vol.20 (10), p.80-14, Article 80

2018

Volltextzugriff (PDF)

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-12, Vol.20 (12), p.100-100, Article 100

2018

Volltextzugriff (PDF)

Abstract P2-08-06: Defining transcriptomic profiles of breast cancer with early lymph node metastases: A FLEX database sub-study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-08-06

2022

Volltextzugriff (PDF)

Abstract P6-10-25: Characterization of the tumor immune microenvironment (TME) in early stage HR-positive HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-10-25

2020

Volltextzugriff (PDF)

Abstract P5-07-05: Deciphering the inferior prognosis of young women with estrogen receptor-positive early-stage breast cancer through full transcriptome analysis: A FLEX database sub-study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-07-05

2022

Volltextzugriff (PDF)

Abstract CT260: The FLEX real-world data platform explores new gene expression profiles and investigator initiated protocols in early stage breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT260-CT260

2021

Volltextzugriff (PDF)

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2798-2798

2019

Volltextzugriff (PDF)

Abstract B11: Prognostic biomarkers in stage II-III melanoma

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.B11-B11

2020

Volltextzugriff (PDF)

Abstract 2091: Quantitative compositional and spatial analysis of tumor microenvironment (TME) in primary melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2091-2091

2018

Volltextzugriff (PDF)

Abstract B005: Linking transcriptomic and imaging features of the melanoma tumor microenvironment

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.B005-B005

2019

Volltextzugriff (PDF)

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Clinical & translational oncology, 2018-11, Vol.20 (11), p.1474-1483

2018

Volltextzugriff (PDF)

Adenoma Detection Rate and Risk of Colorectal Cancer and Death

The New England journal of medicine, 2014-04, Vol.370 (14), p.1298-1306

2014

Volltextzugriff (PDF)

Transcriptomic organization of the human brain in post-traumatic stress disorder

Nature neuroscience, 2021-01, Vol.24 (1), p.24

2021

Volltextzugriff (PDF)

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

JAMA : the journal of the American Medical Association, 2017-04, Vol.317 (16), p.1631

2017

Volltextzugriff (PDF)

1 – 25 von 441

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library All Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(315)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

Bevacizumab in breast cancer: a targeted therapy still in search of a target population

Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

The Role of Oncolytic Viruses in the Treatment of Melanoma

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Abstract P2-08-06: Defining transcriptomic profiles of breast cancer with early lymph node metastases: A FLEX database sub-study

Abstract P6-10-25: Characterization of the tumor immune microenvironment (TME) in early stage HR-positive HER2-positive breast cancer

Abstract P5-07-05: Deciphering the inferior prognosis of young women with estrogen receptor-positive early-stage breast cancer through full transcriptome analysis: A FLEX database sub-study

Abstract CT260: The FLEX real-world data platform explores new gene expression profiles and investigator initiated protocols in early stage breast cancer

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Abstract B11: Prognostic biomarkers in stage II-III melanoma

Abstract 2091: Quantitative compositional and spatial analysis of tumor microenvironment (TME) in primary melanoma

Abstract B005: Linking transcriptomic and imaging features of the melanoma tumor microenvironment

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Adenoma Detection Rate and Risk of Colorectal Cancer and Death

Transcriptomic organization of the human brain in post-traumatic stress disorder

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

Aktive Filter

Suchergebnisse filtern